Heyland, Daren K.
,
van Zanten, Arthur R. H.
Grau-Carmona, Teodoro
Evans, David
Beishuizen, Albertus
Schouten, Jeroen
Hoiting, Oscar
Bordejé, Maria Luisa
Krell, Kenneth
Klein, David J.
Gonzalez, Jesus
Perez, Aitor
Brown, Randy
James, Joyce
Harris, M. Scott http://orcid.org/0000-0001-5141-5773
Funding for this research was provided by:
Lyric Pharmaceuticals
Article History
Received: 12 December 2018
Accepted: 4 March 2019
First Online: 6 May 2019
Compliance with ethical standards
:
: Dr. Heyland served as a consultant to Lyric Pharmaceuticals in the design and execution of this trial. Dr. James, Dr. Harris and Mr. Brown were employees of Lyric Pharmaceuticals. Dr. Gonzalez and Mr. Perez were employees of Pivotal SL, the clinical research organization that conducted the trial on behalf of Lyric.
: The Institutional Review Boards (IRBs)/Independent Ethics Committees (ECs) approved the study protocol at all participating sites.
: The full trial protocol and trial data supporting this publication can be obtained by contacting the corresponding author.
Free to read: This content has been made available to all.